Every few months the longevity world adopts a new favourite molecule, and the pattern is usually the same: a compound extends lifespan in a mouse, a supplement brand appears within the year, and the marketing sprints far ahead of the evidence. C15:0 is a stranger case, and a more interesting one. The molecule at the centre of the 2026 buzz isn't exotic at all — it's a saturated fat found in butter, whole milk and cheese, the exact foods a generation of dietary advice told us to cut. Now a growing body of research is making an audacious claim about it: that pentadecanoic acid is not just harmless but essential — the first new essential fatty acid science has named in roughly 90 years. Here's the honest version of what C15:0 is, why the claim is plausible, and the large asterisk you should keep firmly in view.
The fat we were told to fear
Pentadecanoic acid (chemical formula C15H30O2) is what chemists call an odd-chain saturated fatty acid — its carbon backbone is fifteen atoms long, an oddity in a body that mostly builds fats in even-numbered chains. You get it almost entirely from your diet. Full-fat dairy is the richest source, with smaller amounts in some fish and the meat of grazing ruminants. Your own cells synthesise only trace quantities, which means your blood level of C15:0 is largely a readout of how much dairy fat you eat.[6]
That single fact is why the story is so awkward for nutritional orthodoxy. For decades, dietary guidelines lumped all saturated fat together as something to minimise, and dairy fat took much of the blame. Yet when epidemiologists began measuring individual fatty acids in people's blood rather than asking them to recall what they ate, an inconvenient signal kept surfacing: the people with more of this particular saturated fat in their bloodstream were, if anything, healthier. That's the loose thread the current research pulled on.[1]
What “essential” actually means
In nutrition, “essential” is a technical word, not a compliment. It means a nutrient your body cannot manufacture in sufficient amounts, so you must obtain it from food or suffer a deficiency. The last time science added fatty acids to that list was in the 1920s and 1930s, when the omega-3 and omega-6 families were shown to be indispensable. Since then: nothing. The proposal that C15:0 belongs alongside them — first floated in a 2020 paper provocatively subtitled “could it be essential?” — is therefore a genuinely big scientific claim, which is exactly why it deserves scrutiny rather than applause.[1]
The argument rests on two legs. First, the body can't make enough C15:0 on its own, so intake matters. Second, low levels appear to carry a cost. Researchers have coined the term “cellular fragility syndrome” for a pattern they say emerges when circulating C15:0 drops too low — a state they associate with the metabolic diseases that pile up with age. Whether that syndrome is a real, discrete condition or a re-description of poor metabolic health under a new name is one of the open questions independent scientists are right to press on.[3]
The cellular-fragility idea, and why it's biologically plausible
The most compelling part of the C15:0 case isn't the epidemiology — it's a specific, testable mechanism. Fatty acids don't just fuel cells; they are woven into the membranes that wrap every cell and every mitochondrion inside it. The long, polyunsaturated fats celebrated elsewhere in nutrition — including the omega-3s — are chemically fragile: their double bonds make them prone to oxidation, a kind of molecular rusting. When membrane fats oxidise past a tipping point, the cell can die by a specific route called ferroptosis, an iron-dependent form of cell death that has been tied to aging, cardiovascular disease, type 2 diabetes and fatty liver disease.[3]
C15:0, being saturated and sturdy, is proposed to do the opposite: slot into membranes and stiffen them, making them more resistant to that oxidative unravelling. In this “cellular stability hypothesis,” a membrane starved of C15:0 becomes fragile and prone to ferroptosis, while a well-supplied one holds its structure — a small architectural detail with large downstream consequences for how well tissues age.[3] Laboratory work adds more mechanisms on top: in cell-based assays, C15:0 activated the same metabolic switches (the AMPK energy sensor and PPAR receptors) targeted by established longevity drugs, and one study reported it shared two dozen cellular activities with rapamycin, the most studied longevity compound of all.[2] That's a striking result — and, as we'll see, one worth reading with the funding in mind.
What the human evidence actually shows
Strip away the mechanistic elegance and ask the blunt question: do people with more C15:0 live longer or healthier? Here the strongest evidence is, encouragingly, independent of any supplement company. A 2018 pooled analysis in PLoS Medicine combined sixteen prospective cohorts across twelve countries — more than 63,000 people — and found that higher blood levels of odd-chain fats including C15:0, used as objective markers of dairy-fat intake, were associated with a lower risk of developing type 2 diabetes.[5] Other cohort studies have echoed the theme. In 2,140 older adults in the Cardiovascular Health Study, higher non-esterified C15:0 was associated with a lower risk of heart failure (hazard ratio 0.73 per standard deviation),[11] and a 2021 Swedish cohort plus meta-analysis of 18 observational studies linked higher C15:0 to lower cardiovascular-disease risk (hazard ratio 0.75 per interquintile range; pooled relative risk 0.88 for the highest versus lowest tertile).[12] For a saturated fat, that's a genuinely surprising and repeatedly observed pattern.
But observational data carry a permanent limitation, and it's the same one that haunts every nutrient on this site: correlation can't tell you which way the arrow points. People with higher C15:0 tend to eat more dairy, but they may also differ in dozens of other ways the statistics can't fully erase. And crucially, the leap from “higher natural levels track with better health” to “taking a supplement will make you healthier” is exactly the leap that has embarrassed the supplement field before — think of the omega-3 and antioxidant trials that looked inevitable on paper and then underwhelmed in the clinic. Higher dairy-fat biomarkers being protective does not automatically mean a capsule reproduces the effect.[5]
The first independent human trial
In 2024 the picture changed slightly, because somebody outside the industry finally ran a trial. Researchers at the University of California San Diego gave 30 young adults with overweight or obesity either 200 mg of C15:0 or a placebo daily for 12 weeks, double-blind. The primary question was deliberately modest: does swallowing it actually raise your blood level? It does — circulating C15:0 rose by 1.88 µg/mL more in the supplemented group than in the placebo group, and no significant adverse events occurred.[7]
The more interesting finding was a split inside the treatment group. Only half of those taking the supplement ended the study above 5 µg/mL of circulating C15:0. In that subgroup, liver enzymes fell meaningfully — ALT by 29 U/L and AST by 6 U/L — and haemoglobin rose slightly, compared with the people who did not reach that level.[7] Taken at face value, it hints that there may be a threshold rather than a dose-response, and that response varies between individuals.
Keep the limits in view. Thirty participants, twelve weeks, a young and specific population, and a subgroup analysis that was not the primary endpoint. This is a pharmacokinetic and safety study that found a promising signal, not evidence that C15:0 treats anything. A 2024 French mini-review reached a similar verdict on the essentiality question: the physiological effects are real and reproducible enough to take seriously, but whether C15:0 formally qualifies as essential still needs more work on both criteria.[8]
The catch: read the funding line
Now the part that separates careful readers from headline-skimmers. A large share of the foundational C15:0 research — the essentiality proposal, the cellular stability hypothesis, the rapamycin comparison — shares authors affiliated with Seraphina Therapeutics, the company behind the branded C15:0 supplement sold as fatty15. Several of these papers openly disclose that conflict, to their authors' credit.[2][3][4] But it changes how the evidence should be weighed. When the group generating the science also sells the product, independent replication isn't a nicety — it's the whole game.
This isn't an accusation of fraud; disclosed industry research is normal and often rigorous. It's a call for the ordinary discipline good science demands: wait for the mechanism to be reproduced by labs with nothing to sell, and for the essentiality claim to survive peer scrutiny from nutrition scientists who didn't propose it. Some independent groundwork already exists — the odd-chain fatty acids have been studied for years by academic teams with no commercial stake, including reviews of their metabolism and links to disease.[6] That independent literature is broadly consistent with the idea that C15:0 is benign and possibly beneficial. It is a long way from confirming that it is essential or that a supplement extends human life.
C15:0 versus omega-3
One comparison keeps coming up, partly because C15:0's backers invite it. Company-linked studies have argued that across a battery of human cell-disease systems, C15:0 was active over a broader dose range and looked less prone to a “too much” toxic effect than omega-3 at high concentrations.[4] That framing — a tougher, saturated cousin to the fragile omega-3s — is scientifically coherent and rhetorically convenient at the same time. The honest reading: omega-3s remain among the best-evidenced supplements in all of longevity research, backed by independent randomised trials, including one that nudged a validated aging clock. C15:0 is an intriguing newcomer with a plausible mechanism and promising cell data, but nothing like that depth of independent human evidence yet. They are not in the same weight class — not because C15:0 is a dead end, but because it simply hasn't been tested as hard by people who aren't selling it.
How much C15:0 do you actually get from food?
This is the question that reframes the whole supplement debate, and it is rarely asked. C15:0 makes up roughly 1.2 per cent of the fatty acids in dairy fat — a small share, but dairy fat is not consumed in small amounts.[6][9] Run that percentage through ordinary servings and the numbers land in the same territory as the supplement dose.
| Food | Serving | Fat | C15:0 (estimate) |
|---|---|---|---|
| Butter | 1 tbsp (14 g) | 11.5 g | about 140 mg |
| Cheddar or similar hard cheese | 30 g | 10 g | about 120 mg |
| Whole milk (3.6% fat) | 250 ml | 9 g | about 110 mg |
| Whole-milk yogurt | 150 g | 5 g | about 60 mg |
| Skimmed milk | 250 ml | 0.3 g | under 5 mg |
Estimates, not label values: calculated from the fat in each serving and the share of C15:0 in dairy fat (about 1.2 per cent of total fatty acids). The real share shifts with breed, season and feed, so treat these as the right order of magnitude rather than exact figures.
The implication is blunt. A day containing a splash of whole milk, a slice of cheese and some butter lands in the 200–400 mg range — at or above the dose used in the independent trial. The same day built on skimmed milk and low-fat everything delivers almost none. That is the real variable here, and it is also why C15:0 works so well as a biomarker of dairy fat intake in the first place.[5][10]
Fish contributes a smaller amount, and the meat of grazing ruminants a little more. Plant foods contribute essentially nothing.
Supplement or food: how to decide
Put the two options side by side and the choice gets easier. A supplement delivers a known quantity of purified C15:0 with no saturated fat, no calories and no lactose — which genuinely matters if you avoid dairy, are lactose intolerant, or are tracking an exact intake. It is also the only version with a human trial attached, at 200 mg a day.[7] Commercial products generally fall in the 100–200 mg range.
Food delivers C15:0 in its natural matrix, with protein, calcium and the rest of the dairy fat package — and it is the version that every supportive cohort study actually measured. When researchers pooled 16 prospective cohorts and found higher C15:0 biomarkers linked to lower type 2 diabetes risk, those people were not taking capsules; they were eating dairy.[5] The observational evidence is evidence about food, and transferring it wholesale to a pill is an assumption, not a finding.
If you eat dairy, the honest answer is that you are probably already getting supplement-range amounts and a capsule adds little. If you avoid dairy entirely, a supplement is the only practical route and a reasonable, low-risk experiment. Either way, mind the obvious trade-off: half a block of cheese a day brings several hundred calories and a lot of other saturated fat with it. Use our protein calculator if you want those servings to do double duty.
What a sensible person does now
Underneath the frontier science sits a refreshingly boring, low-regret conclusion. If C15:0 turns out to matter, the easiest way to get it is the way humans always have: a normal amount of full-fat dairy or fish, eaten as food. That path is cheap, delivers the fat in its natural matrix alongside protein and micronutrients, and — on the best independent evidence available — tracks with lower, not higher, metabolic risk. For a compound whose whole story is about dietary fats we misjudged, “eat some cheese and don't panic about it” is a defensible and slightly delicious takeaway.
The supplement is the harder call. It appears safe in the short studies done so far, and if you eat almost no dairy or fish it's a reasonable way to raise your levels. But buy it understanding precisely what you're buying: a promising molecule under active, largely industry-driven investigation — not a validated anti-aging drug, and not yet an officially recognised essential nutrient. Treat it the way you should treat every single molecule we cover: as an optional extra layered on top of the interventions that already have decades of independent human evidence. On that scoreboard, C15:0 still sits far behind regular exercise, good omega-3 intake, decent sleep and not smoking. Watch this one closely. Just keep your hand on your wallet until the independent trials catch up.
Common questions
What is C15:0 (pentadecanoic acid) and where do you get it?
C15:0, or pentadecanoic acid, is an odd-chain saturated fat with the formula C15H30O2. It is found mostly in full-fat dairy — butter, whole milk, cheese and yogurt — plus some fish and, in small amounts, the meat of grazing animals. Your body makes only tiny quantities, so your blood levels depend heavily on what you eat. It is the same dairy fat that low-fat dietary advice spent decades telling people to avoid.
Is C15:0 really an essential fatty acid?
That is the central claim, and it is not yet settled. Proponents argue C15:0 meets the classic definition — the body cannot make enough on its own, and falling short is linked to worse health — which would make it the first essential fatty acid identified since the omega-3s and omega-6s roughly 90 years ago. That case rests mainly on cell studies and observational data, much of it published by the company that sells a C15:0 supplement. An independent 2024 review concluded the molecule may well meet both criteria but that neither has been demonstrated yet, so “essential” remains a strong hypothesis rather than an established fact.
How much C15:0 should I take per day?
There is no official recommended intake, because C15:0 is not yet a recognised essential nutrient. The only published human trial used 200 mg a day for 12 weeks, and commercial supplements generally provide 100 to 200 mg. In that trial, only about half the supplemented participants reached a blood level above 5 µg/mL, which suggests individual response varies considerably at a fixed dose.
How much C15:0 is in butter, milk and cheese?
Dairy fat is roughly 1.2 per cent C15:0, so the amount tracks the fat in the serving. A tablespoon of butter works out at roughly 140 mg, 30 g of hard cheese at roughly 120 mg, and a 250 ml glass of whole milk at roughly 110 mg. Skimmed milk contributes almost nothing. A normal full-fat dairy day therefore lands in the same 200 to 400 mg range as the supplement dose.
Should I take a C15:0 supplement, or just eat dairy?
If you eat full-fat dairy regularly, you are likely already in supplement territory and a capsule adds little. If you avoid dairy — by choice, intolerance or allergy — a supplement is the only practical route and looks low-risk. Worth remembering: every supportive cohort study measured people eating dairy, not people taking pills, so the observational evidence is really evidence about food.
Does C15:0 have side effects?
None of consequence have been reported so far. In the 12-week randomised trial at 200 mg a day there were no significant adverse events, and C15:0 is a normal component of the human diet in similar quantities. The caveat is scale rather than suspicion: the total human safety data amount to a handful of small, short studies, so nothing is known about years of use.
Is C15:0 the same thing as C17:0 or “odd-chain fats”?
They belong to the same family but are not interchangeable. Odd-chain saturated fatty acids are those with an odd number of carbons; the two main ones in the human diet are C15:0 (pentadecanoic acid) and C17:0 (heptadecanoic acid), both from dairy and ruminant fat. C17:0 can be made in the body from C15:0 and from branched-chain amino acids, which is one reason C15:0 is considered the better biomarker of dairy fat intake and has attracted the bulk of the recent research.
Does C15:0 actually slow aging?
Not proven. The longevity framing rests on cell-based work showing C15:0 shares activities with compounds such as rapamycin and metformin, plus the observation that low levels track with poorer metabolic health. No trial has shown that taking C15:0 extends healthy lifespan or slows any marker of biological aging in humans. For context on what has cleared a higher bar, see our guide to the longevity supplements actually worth your money, or the equally early story of nervonic acid, the fatty acid of myelin.